“Eleven vaccines are in late-stage trials, including four in the United States. Pfizer’s progress could bode well for Moderna’s vaccine, which uses similar technology. A Moderna spokesman said that it expected interim findings from its study this month.”— Katie Thomas, David Gelles and Carl Zimmer, nytimes.comTagged: COVID-19, coronavirus, Vaccine, COVID